Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | 1 | X022827 | IM / LA |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X022827 | OT |
No additional AE; The patient received the vaccine for "cochlear implant"; patient received an expired PNEUMOVAX 23 vaccine on 10/13/2025; This spontaneous report was received from a nurse and refers to an 11-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 13-Oct-2025, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) Solution for injection (valid lot #X022827, expiration date reported and confirmed as 14-Aug-2025), 1 dosage form, total (route of administration and anatomical location were not provided) administered for cochlear implant (expired vaccine used / product use in unapproved indication). No additional adverse events reported (no adverse event).